Zhantao Zhang

Title: Zhantao Zhang: Innovator in Pharmaceutical Chemistry

Introduction

Z hantao Zhang is a prominent inventor based in Shandong, China, known for his significant contributions to pharmaceutical chemistry. He holds two patents that showcase his expertise in developing innovative compounds for medical applications. His work focuses on creating effective treatments for conditions driven by tyrosine kinases.

Latest Patents

Zhang's latest patents include a polymorphic form of a compound, which relates to methyl (3R,6S)-6-amino-sulfonylamino-1-(thiazol-2-yl)-3-(2,3,4-trifluorophenyl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-4-formate. This patent details the preparation method and pharmaceutical uses of this compound, emphasizing its potential in drug formulation. Another notable patent involves pyrrolyl substituted dihydroindol-2-one derivatives, which are effective tyrosine kinase inhibitors. This patent also outlines the preparation methods and pharmaceutical compositions containing these compounds, aimed at treating tumors associated with tyrosine kinases.

Career Highlights

Zhang is currently affiliated with Qilu Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has significantly impacted the field of pharmaceuticals, particularly in the development of targeted therapies for cancer treatment.

Collaborations

Zhang collaborates with esteemed colleagues, including Jianwei Shen and Jin Zhang, to further enhance the scope and impact of his research. Their combined expertise fosters innovation and drives the development of new therapeutic solutions.

Conclusion

Z hantao Zhang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in cancer treatment and pharmaceutical development.